Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Adjuvant chemotherapy to fight against resectable gastric cancer

A Novel Dynamic Model identifies Anticancer Target Genes

OsMATE: structural analysis and stress response in Rice

Adjuvant chemotherapy to fight against resectable gastric cancer
  • BiotechToday
  • World

Adjuvant chemotherapy to fight against resectable gastric cancer

BioTech Today July 11, 2021July 10, 2021

Soumya Shraddhya Paul, Amity University, Noida

Gastric cancer is known to be highly prevalent among all the primary gastrointestinal malignancies globally, it is also considered to be the third most deadly cancer. Often it has been noticed that the cases of gastric cancer are prevalent based on geographical areas like Latin America, East/Central Asia, and Eastern Europe are more likely to be affected by this as compared to other parts of the world. Even though we have a lot of advancements when it comes to gastric cancer like early detection, improved medications, etc. Studies showed that still nearly two-third of people having higher risks are being affected by the progression of this disease also known as recurrence. Due to this major reason, Adjuvant or perioperative chemotherapies are being majorly investigated to find an ultimate cure for this disease. S-1 is an oral chemotherapeutic substance seen to have yielded positive output in Asia, S-1 is composed of tegafur, oteracil, and gimeracil. S-1 is seen to be low toxic i.e., without any serious side effects, is also well-tolerated, and is easily available for outpatient settings, currently, it has been approved by Europe and Asia but not the US. Through this study, the scientist tried to show a comparison of platinum-based doublets under D2 gastrectomy as they have not been reported much in real-world experience.

Brief About the Study

For this study scientists took 433 Han Chinese patients who had gastric cancer (perioperative chemotherapies) from the year Jan 2008 to Oct 2018 an observation was being made on patients who received surgery with close observation (OBC), S-1 and Platinum-based doublet (P) the number of patients in this was 221, 67 and 145 respectively. To compare the recurrence-free (RFS )and overall survivals (OS) in patients who were locally advanced in the disease, a propensity score matching was used. Adverse reactions, side effects, dosages that should be administered were also discussed briefly in this study.

Results

A total of 647 people were screened out of which only 433 were eligible for this study a follow-up time of 51.9 months was given, it was noticed that patients who were given S-1 (adjuvant S-1 monotherapy) showed an intermediate level of survival when compared to OBS and P the comparison was done like S-1 vs. OBS, 24.4/40.2 vs. 20.7/27.0 months, HR = 0.62/0.55, p = 0.041/0.024; RFS/OS: S-1 vs. P, 20.9/35.8 vs. 31.2/50.5 months, HR = 1.76/2.14, p = 0.021/0.008. With a dose intensity of 73.6%, S-1 was well tolerated with a median duration of 8.3 months and showed fewer adverse effects or side-effects as compared to others, especially P, a prominent survival difference was noticed in patients with N2–3 diseases. The selection of the S-1 monotherapy was made by the physicians according to the disease stage, age, lymph node stage, and also the serum carcinoembryonic antigen.

Conclusion

It was noted through this study adjuvant S-1 monotherapy has brought a revolution when it comes to Stage II and III gastric cancer especially in people who have received D2 gastrectomy especially in Asia. This study showed a thorough clinical stage of various treatments provided and also showed a comparison between them i.e., S-1 versus close observation and conventional platinum-based chemotherapies.

Also read: HIV vaccine trials re-initiated at Oxford after 40 years

Reference:

Yen, C.-C., Shan, Y.-S., Chao, Y.-J., Liao, T.-K., Chen, I.-S., Huang, H.-Y., Liu, I.-T., & Yen, C.-J. (2021). Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: Real-world experience and a propensity score matching analysis. BMC Cancer, 21(1), 796. https://doi.org/10.1186/s12885-021-08487-z

Author info:

Soumya Shraddhya Paul is an undergrad biotechnology student who worked in building 3D prosthetics in Base Hospital Delhi Cantt, and holds a key interest in nutraceuticals and enzymology.

Social Media Info: www.linkedin.com/in/soumya-shraddhya-paul-858229203

Publications:

  1. https://bioxone.in/news/worldnews/understanding-b-cell-genomics-to-fight-against-covid-19/
  2. https://bioxone.in/news/worldnews/the-current-ebola-epidemic-comes-to-an-end/
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adjuvant chemotherapy D2 gastrectomy gastric cancer gastrointestinal malignancies platinum-based chemotherapies S-1 monotherapy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

OsMATE: structural analysis and stress response in Rice

bioxone July 11, 2021

Husna, Amity University Kolkata Multidrug and toxic compound extrusion (MATE) are protein families that play an important role in various physiological functions of plant growth and development. The MATE gene family is one of the largest families of genes that can encode transporters in plants They can transport secondary metabolites, toxic compounds, and heavy metals; […]

OsMATE

Related Post

  • BiotechToday
  • World

Fast food for Bat guts: Banana Monoculture

bioxone October 2, 2021October 2, 2021

Ananya Ghosal, MAKAUT(WB) The research published in Frontiers in Ecology and Evolution states that the bats which are feeding in organic plantation and natural forest habitat has more types of gut microbes than nectar-feeding bats found in a highly managed banana plantation in Costa Rica. The study presented the relation between sustainable agriculture, habitat alteration […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Antibodies against Nipah Virus found in Mahabaleshwar bats

bioxone June 24, 2021June 23, 2021

Akshita Kumar, M.Sc. Biochemistry A recent study jointly conducted by the Indian Council of Medical Research(ICMR) and the National Institute of Virology(NIV) detected the presence of antibodies against Nipah virus(NiV) in bats residing in a cave in Mahabaleshwar. The sole purpose of this study was to investigate the spread of the Nipah Virus in Indian […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

A memory B cells atlas against SARS-CoV2 viral variants

BioTech Today July 26, 2021July 25, 2021

Kanikah Mehndiratta, MSc, University of Glasgow The SARS-CoV2 virus has been nothing less than devastating to the global population within the last 1 year. The associated COVID-19 (coronavirus disease-2019) is being the center of attention for scientists and doctors worldwide. It helps them understand the underlying pathophysiology so that they can work towards devising appropriate […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy